Advertisement

Mechanisms of resistance to macrolides, lincosamides, and ketolides

  • Joyce A Sutcliffe
  • Roland Leclercq
Chapter
Part of the Milestones in Drug Therapy MDT book series (MDT)

Abstract

Macrolide (M), lincosamide (L), streptogramin B(SB), and ketolide (K) antibiotics are a structurally diverse group of antibiotics that have overlapping binding sites in the peptidyl transferase region of 23S rRNA. Some resistance determinants alter part of the common binding site, thereby reducing susceptibility to more than one of the MLSBK antibiotics simultaneously. The incidence of strains harboring resistance determinants to macrolide-lincosamide-streptogramin (MLSB) antibiotics has risen, especially over the past decade. Further, the microbes have collected mobile elements that help them evade the lethal effects of antibiotics. Bacterial resistance is mounted against MLSBantibiotics on three fronts: 1) target site mutations that prevent the binding of the antibiotic to its natural cellular target (ribosome), 2) efflux of the antibiotic or alterations in the permeability barrier as a means of protection, and 3) inactivation of the antimicrobial substance. Ketolides, a novel semi-synthetic class of 14—membered macrolides, have additional binding contacts within the 50S ribosome, making them less susceptible to some of the more prevalent resistance mechanisms in pathogenic bacteria.

Keywords

Streptococcus Pneumoniae Antimicrob Agent Macrolide Antibiotic Resistance Determinant Macrolide Resistance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kaneko T, McArthur H, Sutcliffe J (2000) Recent developments in the area of macrolide antibiotics. Exp Opin Ther Patents 10: 403–425CrossRefGoogle Scholar
  2. 2.
    Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H (1999) Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 43: 2823–2830PubMedGoogle Scholar
  3. 3.
    Sutcliffe J, Mueller J, Utt E (1999) Antibiotic resistance mechanisms of bacterial pathogens. In Manual of industrial microbiology and biotechnology (AL Demain, JE Davies, (eds).: ASM Press, Washington, D.C. 759–788Google Scholar
  4. 4.
    Weisblum B (2000) Resistance to macrolide-lincosamide-streptogramin antibiotics. In: Gram-positive pathogens (V Fischetti, (ed).: ASM Press, Washington, D.C. 682–698Google Scholar
  5. 5.
    Kirillov S, Porse BT, Vester B, Woolley P, Garrett RA (1997) Movement of the 3’-end of tRNA through the peptidyl transferase centre and its inhibition by antibiotics. FEBS Lett 406: 223–233PubMedCrossRefGoogle Scholar
  6. 6.
    Rodriguez-Fonseca C, Amils R, Garrett RA (1995) Fine structure of the peptidyl transferase centre on 23 S-like rRNAs deduced from chemical probing of antibiotic-ribosome complexes. J Mol Biol 247: 224–235PubMedCrossRefGoogle Scholar
  7. 7.
    Verdier L, Bertho G, Gharbi-Benarous J, Girault J-P (2000) Lincomycin and clindamycin conformations. A fragment shared by macrolides, ketolides and lincosamides determined from TRNOE ribosome-bound conformations. Bioorg Med Chem 8: 1225–1243PubMedCrossRefGoogle Scholar
  8. 8.
    Sor F, Fukuhara H (1982) Identification of two erythromycin resistance mutations in the mitochondrial gene coding for the large ribosomal RNA in yeast. Nucleic Acid Res 10: 6571–6577Google Scholar
  9. 9.
    Vester B, Douthwaite S (2000) Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 45: 1–12CrossRefGoogle Scholar
  10. 10.
    Fu W, Anderson M, Williams S, Tait-Kamradt A, Sutcliffe J, Retsema J (2000) In vitro derived macrolide resistant Streptococcus pneumoniae strains have ribosomal mechanism of resistance, abst. 07–10. In Program and abstracts of the 5th International Conference on Macrolides, Azalides, Streptogramins, Ketolides, and Oxazolidinones, Seville, Spain, 65Google Scholar
  11. 11.
    Tait-Kamradt A, Davies T, Appelbaum PC, Depardieu F, Courvalin P, Petitpas J, Wondrack L, Walker A, Jacobs MR, Sutcliffe J (2000) Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother 44: 3395–3401PubMedCrossRefGoogle Scholar
  12. 12.
    Tait-Kamradt A, Davies T, Cronan M, Jacobs MR, Appelbaum PC, Sutcliffe J (2000) Mutations in 23S rRNA and L4 ribosomal protein account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother 44: 2118–2125PubMedCrossRefGoogle Scholar
  13. 13.
    Canu A, Malbruny B, Coquemont M, Davies TA, Appelbaum PC, Leclercq R (2000) Diversity of mutations in L22, L4 ribosomal proteins and 23S ribosomal RNA in pneumococcal mutants resistant to macrolides, telithromycin, and clindamycin selected in vitro abst. 1927. In Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 118Google Scholar
  14. 14.
    Chittum HS, Champney WS (1994) Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli. J Bacteriol 176: 6192–6198Google Scholar
  15. 15.
    Pardo D, Rosset R (1974) Genetic studies of erythromycin resistant mutants of Escherichia coli. Mol Gen Genet 135: 257–268Google Scholar
  16. 16.
    Schnier J, Gewitz HS, Behrens SE, Lee A, Ginther C, Leighton T (1990) Isolation and characterization of Bacillus stearothermophilus 30S and 50S ribosomal protein mutations. J Bacteriol 172: 7306–7309PubMedGoogle Scholar
  17. 17.
    Sharrock RA, Leighton T, Wittmann HG (1981) Macrolide and aminoglycoside antibiotic resistance mutations in the Bacillus subtilis ribosome resulting in temperature-sensitive sporulation. Mol Gen Genet 183: 538–543PubMedCrossRefGoogle Scholar
  18. 18.
    Tipper DJ, Johnson CW, Ginther CL, Leighton T, Wittmann HG (1977) Erythromycin resistant mutations in Bacillus subtilis cause temperature sensitive sporulation. Mol Gen Genet 150: 147–159PubMedCrossRefGoogle Scholar
  19. 19.
    Weisblum B (1995) Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 39: 577–585PubMedCrossRefGoogle Scholar
  20. 20.
    Wittmann HG, Stoffler G, Apirion D, Rosen L, Tanaka K, Tamaki M, Takata R, Dekio S, Otaka E (1973) Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins. Mol Gen Genet 127: 175–189PubMedCrossRefGoogle Scholar
  21. 21.
    Sutcliffe J, Tait-Kamradt A, Walker A, Petitpas J (2000) Macrolide resistance in pneumococci: Analysis of resistant isolates obtained by passage with telithromycin, abst. 1925. In Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chermotherapy, Toronto, Ontario, Canada, 117Google Scholar
  22. 22.
    Gregory ST, Dahlberg AE (1999) Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23 S ribosomal RNA. J Mol Biol 289: 827–834PubMedCrossRefGoogle Scholar
  23. 23.
    Ban N, Nissen P, Hansen J, Moore PB, Steitz TA (2000) The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science 289: 905–920PubMedCrossRefGoogle Scholar
  24. 24.
    Malbruny B, Canu A, Bozdogan B, Fantin B, Leclercq R (2000) Quinupristin/Dalfopristin Resistance Mutation Reveals the Involvement of L22 Ribosomal Protein in Synergy Between Quinupristin and Dalfopristin, abst. 1928. In Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 118Google Scholar
  25. 25.
    Baranov PV, Kubarenko AV, Gurvich OL, Shamolina TA, Brimacombe R (1999) The Database of Ribosomal Cross-links: an update. Nucleic Acids Res 27: 184–185PubMedCrossRefGoogle Scholar
  26. 26.
    Hansen HL, Mauvais P, Douthwaite S (1999) The macrolide-ketolide antibiotic binding site is formed by structures in domain II and V of 23S ribosomal RNA. Mol Microbiol 31: 623–631PubMedCrossRefGoogle Scholar
  27. 27.
    Poulsen SM, Kofoed C, Vester B (2000) Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin. J Mol Biol 304: 471–481PubMedCrossRefGoogle Scholar
  28. 28.
    Douthwaite 5, Hansen LH, Mauvais P (2000) Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. Mol Microbiol 36: 183–193PubMedCrossRefGoogle Scholar
  29. 29.
    Xiong L, Shah S, Mauvais P, Mankin AS (1999) A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre. Mol Microbiol 31: 633–639PubMedCrossRefGoogle Scholar
  30. 30.
    Mankin A (2000) Interaction of Macrolides with the Ribosome, abst. 1132. In Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 534Google Scholar
  31. 31.
    Asai T, Condon C, Voulgaris J, Zaporojets D, Shen B, Al-Omar M, Squires C, Squires CL (1999) Construction and initial characterization of Escherichia coli strains with few or no intact chromosomal rRNA operons. J Bacteriol 181: 3803–3809PubMedGoogle Scholar
  32. 32.
    Ettayebi M, Prasad SM, Morgan EA (1985) Chloramphenicol-erythromycin resistance mutations in a 23S rRNA gene of Escherichia coli. J Bacteriol 162: 551–557Google Scholar
  33. 33.
    Douthwaite S, Aagaard C (1993) Erythromycin binding is reduced in ribosomes with conformational alterations in the 23 S rRNA peptidyl transferase loop. J Mol Biol 232: 725–731PubMedCrossRefGoogle Scholar
  34. 34.
    Douthwaite S (1992) Functional interactions within 23S rRNA involving the peptidyltransferase center. J Bacteriol 174: 1333–1338PubMedGoogle Scholar
  35. 35.
    Douthwaite S, Prince JB, Noller HF (1985) Evidence for functional interaction between domains II and V of 23S ribosomal RNA from an erythromycin-resistant mutant. Proc Natl Acad Sci USA 82: 8330–8334PubMedCrossRefGoogle Scholar
  36. 36.
    Tenson T, DeBlasio A, Mankin A (1996) A functional peptide encoded in the Escherichia coli 23S rRNA. Proc Nall Acad Sci USA 93: 5641–5646CrossRefGoogle Scholar
  37. 37.
    Tenson T, Xiong L, Kloss P, Mankin AS (1997) Erythromycin resistance peptides selected from random peptide libraries. J Biol Chem 272: 17425–17430PubMedCrossRefGoogle Scholar
  38. 38.
    Dam M, Douthwaite S, Tenson T, Mankin AS (1996) Mutations in domain II of 23 S rRNA facilitate translation of a 23 S rRNA-encoded pentapeptide conferring erythromycin resistance. J Mol Biol 259: 1–6PubMedCrossRefGoogle Scholar
  39. 39.
    Tripathi S, Kloss PS, Mankin AS (1998) Ketolide resistance conferred by short peptides. J Biol Chem 273: 20073–20077PubMedCrossRefGoogle Scholar
  40. 40.
    Chabbert Y (1956) Antagonisme in vitro entre l’erythromycine et la spiramycine. Ann Inst Pasteur (Paris) 90: 787–790Google Scholar
  41. 41.
    Garrod LP (1957) The erythromycin group of antibiotics. Br Med J 2: 57–63PubMedCrossRefGoogle Scholar
  42. 42.
    Jones WF, Nichols RF, Finland M (1966) Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, oleandomycin and streptogramin. Proc Soc Experiment Biol Med 93: 388–393Google Scholar
  43. 43.
    Fernandez-Munoz R, Monro RE, Torres-Pinedo R, Vazquez D (1971) Substrate-and antibiotic-binding sites at the peptidyl-transferase centre of Escherichia coli ribosomes. Studies on the chloramphenicol, lincomycin and erythromycin sites. Eur J Biochem 23: 185–193PubMedCrossRefGoogle Scholar
  44. 44.
    Moazed D, Noller HF (1987) Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA. Biochimie 69: 879–884PubMedCrossRefGoogle Scholar
  45. 45.
    Sander P, Prammananan T, Meier A, Frischkom K, Bottger EC (1997) The role of ribosomal RNAs in macrolide resistance. Mol Microbiol 26: 469–480PubMedCrossRefGoogle Scholar
  46. 46.
    Pemodet JL, Fish S, Blondelet-Rouault MH, Cundliffe E (1996) The macrolide-lincosamidestreptogramin B resistance phenotypes characterized by using a specifically deleted, antibiotic-sensitive strain of Streptomyces lividans. Antimicrob Agents Chemother 40: 581–585Google Scholar
  47. 47.
    Capobianco JO, Cao Z, Shortridge VD, Ma Z, Flamm RK, Zhong P (2000) Studies of the novel ketolide ABT-773: transport, binding to ribosomes, and inhibition of protein synthesis in Streptococcus pneumoniae. Antimicrob Agents Chemother 44: 1562–1567CrossRefGoogle Scholar
  48. 48.
    Denis A, Agouridas C, Auger JM, Benedetti Y, Bonnefoy A, Bretin F, Chantot JF, Dussarat A, Fromentin C, D’Ambrieres SG, Lachaud S, Laurin P, Le Martret 0, Loyau V, Tessot N, Pejac JM, Perron S (1999) Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. Bioorg Med Chem Lett 9: 3075–3080Google Scholar
  49. 49.
    Goldman RC, Kadam SK (1989) Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth. Antimicrob Agents Chemother 33: 1058–1066PubMedCrossRefGoogle Scholar
  50. 50.
    Arthur M, Brisson-Noel A, Courvalin P (1987) Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses. J Antimicrob Chemother 20: 783–802PubMedCrossRefGoogle Scholar
  51. 51.
    Seppala H, Skumik M, Soini H, Roberts MC, Huovinen P (1998) A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 42: 257–262Google Scholar
  52. 52.
    Cundliffe E (1992) Self-protection mechanisms in antibiotic producers. Ciba Found Symp 171: 199–208PubMedGoogle Scholar
  53. 53.
    Hara Q, Hutchinson CR (1990) Cloning of midecamycin (MLS)-resistance genes from Streptomyces mycarofaciens Streptomyces lividans and Streptomyces coelicolor A3. J Antibiot 43: 977–991PubMedCrossRefGoogle Scholar
  54. 54.
    Pereda A, Summers R, Katz L (1997) Nucleotide sequence of the ermE distal flank of the erythromycin biosynthesis cluster in Saccharopolyspora erythraea. Gene 193: 65–71Google Scholar
  55. 55.
    Fouces R, Mellando E, Diez B, Barredo JL (1999) The tylosin biosynthetic cluster from Streptomyces fradiae: genetic organization of the left region. Microbiology 145: 855–868PubMedCrossRefGoogle Scholar
  56. 56.
    Liu M, Kirpekar F, Van Wezel GP, Douthwaite S (2000) The tylosin resistance gene tlrB of Streptomyces fradiae encodes a methyltransferase that targets G748 in 23S rRNA. Mol Microbiol 37: 811–820PubMedCrossRefGoogle Scholar
  57. 57.
    Gustafsson C, Persson BC (1998) Identification of the rrmA gene encoding the 23S rRNA m’G745 methyltransferase in Escherichia coli and characterization of an m’G745-deficient mutant. J Bacteriol 180: 359–365PubMedGoogle Scholar
  58. 58.
    Pemodet JL, Gourmelen A, Blondelet-Rouault MH, Cundliffe E (1999) Dispensable ribosomal resistance to spiramycin conferred by srmA in the spiramycin producer Streptomyces ambofaciens. Microbiology 145: 2355–2364Google Scholar
  59. 59.
    Arisawa A, Tsunekawa H, Okamura K, Okamoto R (1995) Nucleotide sequence analysis of the carbomycin biosynthetic genes including the 3–0-acyltransferase gene from Streptomyces thermotolerans. Biosci Biotechnol Biochem 59: 582–588CrossRefGoogle Scholar
  60. 60.
    Quiros LM, Aguirrezabalaga I, Olano C, Mendez C, Salas JA (1998) Two glycosyltransferases and a glycosidase are involved in oleandomycin modification during its biosynthesis by Streptomyces antibioticus. Mol Microbiol 28: 1177–1185CrossRefGoogle Scholar
  61. 61.
    Schmitz FJ, Sadurski R, Kray A, Boos M, Geisel R, Kohrer K, Verhoef J, Fluit AC (2000) Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother 45: 891–894PubMedCrossRefGoogle Scholar
  62. 62.
    Portillo A, Ruiz-Larrea F, Zarazaga M, Alonso A, Martinez JL, Torres C (2000) Macrolide resistance genes in Enterococcus spp. Antimicrob Agents Chemother 44: 967–971PubMedCrossRefGoogle Scholar
  63. 63.
    Syrogiannopoulos GA, Grivea IN, Tait-Kamradt A, Katopodis GD, Beratis NG, Sutcliffe J, Appelbaum PC, Davies TD (2000) Identification of erm(A) Erythromycin Resistance Methylase Gene in Streptococcus pneumoniae Isolated in Greece. Antimicrob Agents Chemother 45: 342–344CrossRefGoogle Scholar
  64. 64.
    Felsenstein J (1988) Phylogenies from molecular sequences: inference and reliability. Annu Rev Genet 22: 521–565PubMedCrossRefGoogle Scholar
  65. 65.
    Yu L, Petros AM, Schnuchel A, Zhong P, Severin JM, Walter K, Holzman TF, Fesik SW (1997) Solution structure of an rRNA methyltransferase (ErmAM) that confers macrolide-lincosamidestreptogramin antibiotic resistance. Nat Struct Biol 4: 483–489PubMedCrossRefGoogle Scholar
  66. 66.
    Schluckebier G, Zhong P, Stewart KD, Kavanaugh TJ, Abad-Zapatero C (1999) The 2.2 A structure of the rRNA methyltransferase ErmC’ and its complexes with cofactor and cofactor analogs: implications for the reaction mechanism. J Mol Biol 289: 277–291PubMedCrossRefGoogle Scholar
  67. 67.
    Bussiere DE, Muchmore SW, Dealwis CG, Schluckebier G, Nienaber VL, Edalji RP, Walter KA, Ladror US, Holzman TF, Abad-Zapatero C (1998) Crystal structure of ErmC’, an rRNA methyltransferase which mediates antibiotic resistance in bacteria. Biochemistry 37: 7103–7112PubMedCrossRefGoogle Scholar
  68. 68.
    Clancy J, Schmieder BJ, Petitpas JW, Manousos M, Williams JA, Faiella JA, Girard AE, McGuirk PR (1995) Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. J Antibiot 48: 1273–1279PubMedCrossRefGoogle Scholar
  69. 69.
    Hanessian S, Sgarbi PWM (2000) Design and synthesis of mimics of S-adenosyl-L-homocysteine as potential inhibitors of erythromycin methyltransferases. Bioorg Med Chem Lett 10: 433–437PubMedCrossRefGoogle Scholar
  70. 70.
    Hajduk PJ, Dinges J, Schkeryantz JM, Janowick D, Kaminski M, Tufano M, Augeri DJ, Petros A, Nienaber V, Zhong P, Hammond R, Coen M, Beutel B, Katz L, Fesik SW (1999) Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis. J Med Chem 42: 3852–3859PubMedCrossRefGoogle Scholar
  71. 71.
    Horinouchi S, Weisblum B (1980) Posttranscriptional modification of mRNA conformation: mechanism that regulates erythromycin-induced resistance. Proc Natl Acad Sci USA 77: 7079–7083PubMedCrossRefGoogle Scholar
  72. 72.
    Gryczan TJ, Grandi G, Hahn J, Grandi R, Dubnau D (1980) Conformational alteration of mRNA structure and the posttranscriptional regulation of erythromycin-induced drug resistance. Nucleic Acids Res 8: 6081–6097PubMedCrossRefGoogle Scholar
  73. 73.
    Rosato A, Vicarini H, Leclercq R (1999) Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin. J Antimicrob Chemother 43: 559–562PubMedCrossRefGoogle Scholar
  74. 74.
    Weisblum B (1995) Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob Agents Chemother 39: 797–805PubMedCrossRefGoogle Scholar
  75. 75.
    Sandler P, Weisblum B (1989) Erythromycin-induced ribosome stall in the ermA leader: a barricade to 5’-to-3’ nucleolytic cleavage of the ermA transcript. J Bacteriol 171: 6680–6688PubMedGoogle Scholar
  76. 76.
    Bechhofer DH, Dubnau D (1987) Induced mRNA stability in Bacillus subtilis. Proc Nall Acad Sci USA 84: 498–502CrossRefGoogle Scholar
  77. 77.
    Denoya CD, Bechhofer DH, Dubnau D (1986) Translational autoregulation of ermC 23S rRNA methyltransferase expression in Bacillus subtilis. J Bacteriol 168: 1133–1141Google Scholar
  78. 78.
    Horinouchi S, Byeon W-H, Weisblum B (1983) A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis. J Bacteriol 154: 1252–1262Google Scholar
  79. 79.
    Monod M, Mohan S, Dubnau D (1987) Cloning and analysis of ermG a new macrolidelincosamide-streptogramin B resistance element from Bacillus sphaericus. J Bacteriol 169: 340–350PubMedGoogle Scholar
  80. 80.
    Kwak JH, Choi EC, Weisblum B (1991) Transcriptional attenuation control of ennK a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus lichenifonnis. J Bacteriol 173: 4725–4735Google Scholar
  81. 81.
    Choi SS, Kim SK, Oh TG, Choi EC (1997) Role of mRNA termination in regulation of ermK. J Bacteriol 179: 2065–2067Google Scholar
  82. 82.
    Gryczan T, Israeli-Reches M, Del Bue M, Dubnau D (1984) DNA sequence and regulation of ermD a macrolide-lincosamide-streptogramin B resistance element from Bacillus licheniformis. Mol Gen Genet 194: 349–356CrossRefGoogle Scholar
  83. 83.
    Kamimiya S, Weisblum B (1988) Translational attenuation control of ermSF an inducible resistance determinant encoding rRNA N-methyltransferase from Streptomyces fradiae. J Bacteriol 170: 1800–1811Google Scholar
  84. 84.
    Kelemen GH, Zalacain M, Culebras E, Seno ET, Cundliffe E (1994) Transcriptional attenuation control of the tylosin-resistance gene tlrA in Streptomyces fradiae. Mol Microbiol 14: 833–842CrossRefGoogle Scholar
  85. 85.
    Lampson BC, Parisi JT (1986) Naturally occurring Staphylococcus epidermidis plasmid expressing constitutive macrolide-lincosamide-streptogramin B resistance contains a deleted attenuator. J Bacteriol 166: 479–483PubMedGoogle Scholar
  86. 86.
    Martin B, Alloing G, Mejean V, Claverys JP (1987) Constitutive expression of erythromycin resistance mediated by the ermAM determinant of plasmid pAM beta 1 results from deletion of 5’ leader peptide sequences. Plasmid 18: 250–253PubMedCrossRefGoogle Scholar
  87. 87.
    Tannock GW, Luchansky JB, Miller L, Connell H, Thode-Andersen S, Mercer AA, Klaenhammer TR (1994) Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ennGT) from Lactobacillus reuteri 100–63. Plasmid 31: 60–71PubMedCrossRefGoogle Scholar
  88. 88.
    Oliveira SS, Murphy E, Gamon MR, Bastos MC (1993) pRJ5: a naturally occurring Staphylococcus aureus plasmid expressing constitutive macrolide-lincosamide-streptogramin B resistance contains a tandem duplication in the leader region of the ennC gene. J Gen Microbiol 139 (Pt 7): 1461–1467PubMedCrossRefGoogle Scholar
  89. 89.
    Lodder G, Werckenthin C, Schwarz S, Dyke K (1997) Molecular analysis of naturally occuring ermC-encoding plasmids in staphylococci isolated from animals with and without previous contact with macrolide/lincosamide antibiotics. FEMS Immun Med Microbiol 18: 7–15CrossRefGoogle Scholar
  90. 90.
    Leclercq R, Bauduret F, Soussy CJ (1989) Selection of constitutive mutants of gram-positive cocci inducible resistant to macrolides, lincosamides and streptogramins (MLS): comparison of the selective effects of the MLS. Pathol Biol (Paris) 37: 568–572Google Scholar
  91. 91.
    Hahn J, Grandi G, Gryczan Ti, Dubnau D (1982) Translational attenuation of ennC: a deletion analysis. Mol Gen Genet 186: 204–216PubMedCrossRefGoogle Scholar
  92. 92.
    Watanakunakorn C (1976) Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. Am J Med 60: 419–425PubMedCrossRefGoogle Scholar
  93. 93.
    Kamimiya S, Weisblum B (1997) Induction of ermSV by 16-membered-ring macrolide antibiotics. Antimicrob Agents Chemother 41: 530–534PubMedGoogle Scholar
  94. 94.
    Oh TG, Kwon AR, Choi EC (1998) Induction of ermAMR from a clinical strain of Enterococcus faecalis by 16-membered-ring macrolide antibiotics. J Bacteriol 180: 5788–5791PubMedGoogle Scholar
  95. 95.
    Bonnefoy A, Girard AM, Agouridas C, Chantot JF (1997) Ketolides lack inducibility properties of MLS(B) resistance phenotype. J Antimicrob Chemother 40: 85–90PubMedCrossRefGoogle Scholar
  96. 96.
    Zhong P, Cao Z, Hammond R, Chen Y, Beyer J, Shortridge VD, Phan LY, Pratt S, Capobianco J, Reich KA, Flamm RK, Or YS, Katz L (1999) Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides. Microb Drug Resist 5: 183–188PubMedCrossRefGoogle Scholar
  97. 97.
    Saito T, Shimizu M, Mitsuhashi S (1971) Macrolide resistance in staphylococci. Ann New York Acad Sci 182: 267–278CrossRefGoogle Scholar
  98. 98.
    Sutcliffe J, Tait-Kamradt A, Brennan L, Duignan J, Wondrack L, Walker A, Baima E, Mueller J (2000) Heterogeneous ketolide resistance in erm(B)’ Streptococcus pneumoniae strains, abst. 1926. In Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, p. 117, Toronto, Ontario, CanadaGoogle Scholar
  99. 99.
    Marshall VP, Cialdella JI, Baczynskyj L, Liggett WF, Johnson RA (1989) Microbial 0- phosphorylation of macrolide antibiotics. J Antibiot 42: 132–134PubMedCrossRefGoogle Scholar
  100. 100.
    Wiley PF, Baczynskyj L, Dolak LA, Cialdella JI, Marshall VP (1987) Enzymatic phosphorylation of macrolide antibiotics. J Antibiot 40: 195–201PubMedCrossRefGoogle Scholar
  101. 101.
    Marshall VP, Liggett WF, Cialdella JI (1989) Enzymic inactivation of lincosaminide and macrolide antibiotics: divalent metal cation and coenzyme specificities. J Antibiot 42: 826–830PubMedCrossRefGoogle Scholar
  102. 102.
    Katayama J, Okada H, O’Hara K, Noguchi N (1998) Isolation and characterization of two plasmids that mediate macrolide resistance in Escherichia coli: transferability and molecular properties. Biol Pharm Bull 21: 326–329PubMedCrossRefGoogle Scholar
  103. 103.
    Katayama J, Noguchi N (1999) Nucleotide sequence of the gene cluster containing the mphB gene for macrolide 2’-phosphotransferase II. Biol Pharm Bull 22: 227–228PubMedCrossRefGoogle Scholar
  104. 104.
    Kim S-K, Baek M-C, Choi S-S, Kim B-K, Choi E-C (1996) Nucleotide sequence, expression and transcriptional analysis of the Escherichia coli mphK gene encoding macrolide-phosphotransferase K. Mol Cells 6: 153–160Google Scholar
  105. 105.
    Kono M, O’Hara K, Ebisu T (1992) Purification and characterization of macrolide 2’-phosphotransferase type II from a strain of Escherichia coli highly resistant to macrolide antibiotics. FEMS Microbiol Lett 76: 89–94PubMedGoogle Scholar
  106. 106.
    Leclercq R, Courvalin P (1991) Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 35: 1267–1272PubMedCrossRefGoogle Scholar
  107. 107.
    Leclercq R, Courvalin P (1991) Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob Agents Chemother 35: 1273–1276PubMedCrossRefGoogle Scholar
  108. 108.
    Matsuoka M, Endou K, Kobayashi H, Inoue M, Nakajima Y (1997) A dyadic plasmid that shows MLS and PMS resistance in Staphylococcus aureus. FEMS Microbiol Lett 148: 91–96CrossRefGoogle Scholar
  109. 109.
    Matsuoka M, Endou K, Kobayashi H, Inoue M, Nakajima Y (1998) A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus. FEMS Microbiol Lett 167: 221–227CrossRefGoogle Scholar
  110. 110.
    Noguchi N, Emura A, Matsuyama H, O’Hara K, Sasatsu M, Kono M (1995) Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2’-phosphotransferase I in Escherichia coli. Antimicrob Agents Chemother 39: 2359–2363CrossRefGoogle Scholar
  111. 111.
    Noguchi N, Katayama J, O’Hara K (1996) Cloning and nucleotide sequence of the mphB gene for macrolide 2’- phosphotransferase II in Escherichia coli. FEMS Microbiol Lett 144: 197–202Google Scholar
  112. 112.
    Noguchi N, Tamura Y, Katayama J, Narui K (1998) Expression of the mphB gene for macrolide 2’-phosphotransferase II from Escherichia coli in Staphylococcus aureus. FEMS Microbiol Lett 159: 337–342Google Scholar
  113. 113.
    Noguchi N, Katayama J (1998) Expression in Pseudomonas aeruginosa of an erythromycin-resistance determinant that encodes the mphA gene for macrolide 2’-phosphotransferase I from Escherichia coli. Biol Pharm Bull 21: 191–193Google Scholar
  114. 114.
    O’Hara K, Kanda T, Ohmiya K, Ebisu T, Kono M (1989) Purification and characterization of macrolide 2’-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob Agents Chemother 33: 1354–1357PubMedCrossRefGoogle Scholar
  115. 115.
    O’Hara K, Kawabe T, Taniguchi K, Nakamura A, Sawai T (1997) A new macrolide 2’phosphotransferase in E. coli abst. C-67. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy p. 57, Toronto, Ontario, CanadaGoogle Scholar
  116. 116.
    O’Hara K, Yamamoto K (1996) Reaction of roxithromycin and clarithromycin with macrolideinactivating enzymes from highly erythromycin-resistant Escherichia coli. Antimicrob Agents Chemother 40: 1036–1038Google Scholar
  117. 117.
    Taniguchi K, Nakamura A, Tsurubuchi K, Ishii A, O’Hara K, Sawai T (1999) Identification of functional amino acids in the macrolide 2’- phosphotransferase II. Antimicrob Agents Chemother 43: 2063–2065PubMedGoogle Scholar
  118. 118.
    Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L (1996) Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40: 2562–2566PubMedGoogle Scholar
  119. 119.
    Cheng J, Grebe T, Wondrack L, Courvalin P, Sutcliffe J (1999) Characterization of genes involved in erythromycin resistance in a clinical strain of Staphylococcus aureus abst. 837. In rogram and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. p. 114, San Francisco, CAGoogle Scholar
  120. 120.
    Ainsa JA, Blokpoel MC, Otal I, Young DB, De Smet KA, Martin C (1998) Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J Bacteriol 180: 5836–5843Google Scholar
  121. 121.
    Ross JI, Farrell AM, Eady EA, Cove JH, Cunliffe WJ (1989) Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J Antimicrob Chemother 24: 851–862CrossRefGoogle Scholar
  122. 122.
    Taniguchi K, Nakamura A, Tsurubuchi K, Ishii A, O’Hara K, Sawai T (1999) Appearance in Japan of highly macrolide-resistant Escherchia coli producing macrolide 2’-phosphotransferace II. Microbios 97: 137–144PubMedGoogle Scholar
  123. 123.
    Alonso A, Sanchez P, Martinez JL (2000) Stenotrophomonas maltophilia D457R contains a cluster of genes from Gram-positive bacteria involved in antibiotic and heavy metal resistance. Antimicrob Agents Chemother 44: 1778–1782PubMedCrossRefGoogle Scholar
  124. 124.
    Yazawa K, Mikami Y, Sakamoto T, Ueno Y, Morisaki N, Iwasaki S, Furihata K (1994) Inactivation of the macrolide antibiotics erythromycin, midecamycin, and rokitamycin by pathogenic Nocardia species. Antimicrob Agents Chemother 38: 2197–2199PubMedCrossRefGoogle Scholar
  125. 125.
    Arthur M, Autissier D, Courvalin P (1986) Analysis of the nucleotide sequence of the ereB gene encoding the erythromycin esterase type II. Nucleic Acids Res 14: 4987–4999PubMedCrossRefGoogle Scholar
  126. 126.
    Ounissi H, Courvalin P (1985) Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli. Gene 35: 271–278Google Scholar
  127. 127.
    Arthur M, Andremont A, Courvalin P (1987) Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob Agents Chemother 31: 404–409PubMedCrossRefGoogle Scholar
  128. 128.
    Plante I, Roy PH (1998) Sequencing and PCR mapping of integrons reveals a novel combination of resistance genes and an ereA gene cassette in the multiresistant strain Providencia stuartii 1723. GenBank accession number X03988 Google Scholar
  129. 129.
    Wondrack L, Massa M, Yang BV, Sutcliffe J (1996) Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob Agents Chemother 40: 992–998PubMedGoogle Scholar
  130. 130.
    Barthelemy P, Autissier D, Gerbaud G, Courvalin P (1984) Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance. J Antibiot 37: 1692–1696PubMedCrossRefGoogle Scholar
  131. 131.
    Sasaki J, Mizoue K, Morimoto S, Omura S (1996) Microbial glycosylation of macrolide antibiotics by Streptomyces hygroscopicus ATCC 31080 and distribution of a macrolide glycosyl transferase in several Streptomyces strains. J Antibiot 49: 1110–1118PubMedCrossRefGoogle Scholar
  132. 132.
    Jenkins G, Cundliffe E (1991) Cloning and characterization of two genes from Streptomyces lividans that confer inducible resistance to lincomycin and macrolide antibiotics. Gene 108: 55–62PubMedCrossRefGoogle Scholar
  133. 133.
    Cundliffe E (1992) Resistance to macrolides and lincosamides in Streptomyces lividans and to aminoglycosides in Micromonospora purpurea. Gene 115: 75–84Google Scholar
  134. 134.
    Kuo MS, Chirby DG, Argoudelis AD, Cialdella JI, Coats JH, Marshall VP (1989) Microbial glycosylation of erythromycin A. Antimicrob Agents Chemother 33: 2089–2091PubMedCrossRefGoogle Scholar
  135. 135.
    Schulman M, Doherty P, Arison B (1993) Microbial conversion of avermectins by Saccharopolyspora erythraea: glycosylation at C-4’ and C-4“. Antimicrob Agents Chemother 37: 1737–1741PubMedCrossRefGoogle Scholar
  136. 136.
    Nikaido H (1998) Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin Infect Dis 27 Suppl 1: S32—S41PubMedCrossRefGoogle Scholar
  137. 137.
    Germ M, Yoshihara E, Yoneyama H, Nakae T (1999) Interplay between the efflux pump and the outer membrane permeability barrier in fluorescent dye accumulation in Pseudomonas aeruginosa. Biochem Biophys Res Commun 261: 452–455CrossRefGoogle Scholar
  138. 138.
    Li XZ, Zhang L, Poole K (2000) Interplay between the MexA-MexB-oprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J Antimicrob Chemother 45: 433–436CrossRefGoogle Scholar
  139. 139.
    Saier J, M.H., Beaty JT, Goffeau A, Harley KT, Heijne WHM, Huang S-C, Jack DL, Jahn PS, Lew K, Liu J, Pao SS, Paulsen IT, Tseng T-T, Virk PS (1999) The major facilitator superfamily. J Mol Microbiol Biotechnol 1: 257–279Google Scholar
  140. 140.
    Zgurskaya HI, Nikaido H (1999) Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc Natl Acad Sci USA 96: 7190–7195CrossRefGoogle Scholar
  141. 141.
    Zgurskaya HI, Nikaido H (1999) AcrA is a highly asymmetric protein capable of spanning the periplasm. J Mol Biol 285: 409–420PubMedCrossRefGoogle Scholar
  142. 142.
    Koronakis V, Sharff A, Koronakis E, Luisi B, Hughes C (2000) Crystal structure of the bacterial membrane protein To1C central to multidrug efflux and protein export. Nature 405: 914–919PubMedCrossRefGoogle Scholar
  143. 143.
    Mine T, Morita Y, Kataoka A, Mizushima T, Tsuchiya T (1999) Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob Agents Chemother 43: 415–417Google Scholar
  144. 144.
    Zhao Q, Li XZ, Srikumar R, Poole K (1998) Contribution of outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB. Antimicrob Agents Chemother 42: 1682–1688PubMedGoogle Scholar
  145. 145.
    Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T (2000) Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44: 2242–2246CrossRefGoogle Scholar
  146. 146.
    Zhang L, Li XZ, Poole K (2000) Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system. Antimicrob Agents Chemother 44: 287–293PubMedCrossRefGoogle Scholar
  147. 147.
    Lucas CE, Hagman KE, Levin JC, Stein DC, Shafer WM (1995) Importance of lipooligosaccharide structure in determining gonococcal resistance to hydrophobic antimicrobial agents resulting from the mtr efflux system. Mol Microbiol 16: 1001–1009PubMedCrossRefGoogle Scholar
  148. 148.
    De Rossi E, Branzoni M, Cantoni R, Milano A, Riccardi G, Ciferri 0 (1998) mmr a Mycobacterium tuberculosis gene conferring resistance to small cationic dyes and inhibitors. J Bacteriol 180: 6068–6071PubMedGoogle Scholar
  149. 149.
    Edgar R, Bibi E (1997) MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J Bacteriol 179: 2274–2280PubMedGoogle Scholar
  150. 150.
    Jager W, Kalinowski J, Puhler A (1997) A Corynebacterium glutamicum gene conferring multidrug resistance in the heterologous host Escherichia coli. J Bacterial 179: 2449–2451Google Scholar
  151. 151.
    Edgar R, Bibi E (1999) A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA. EMBO J 18: 822–832PubMedCrossRefGoogle Scholar
  152. 152.
    Zheleznova EE, Markham P, Edgar R, Bibi E, Neyfakh AA, Brennan RG (2000) A structure-based mechanism for drug binding by multidrug transporters. Trends Biochem Sci 25: 39–43PubMedCrossRefGoogle Scholar
  153. 153.
    Zheleznova EE, Markham PN, Neyfakh AA, Brennan RG (1999) Structural basis of multidrug recognition by BmrR, a transcription activator of a multidrug transporter. Cell 96: 353–362PubMedCrossRefGoogle Scholar
  154. 154.
    Tait-Kamradt A, Clancy J, Cronan M, Dib-Hajj F, Wondrack L, Yuan W, Sutcliffe J (1997) mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother 41: 2251–2255PubMedGoogle Scholar
  155. 155.
    Sutcliffe J, Tait-Kamradt A, Wondrack L (1996) Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system . Antimicrob Agents Chemother 40: 1817–1824PubMedGoogle Scholar
  156. 156.
    Clancy J, Petitpas J, Dib-Hajj F, Yuan W, Cronan M, Kamath AV, Bergeron J, Retsema JA (1996) Molecular cloning and functional analysis of a novel macrolide-resistance determinant mefA from Streptococcus pyogenes. Mol Microbiol 22: 867–879CrossRefGoogle Scholar
  157. 157.
    Johnston NJ, De Azavedo JC, Kellner JD, Low DE (1998) Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 42: 2425–2426Google Scholar
  158. 158.
    Klugman KP, Capper T, Widdowson CA, Koonthof HJ, Moser W (1998) Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. J Antimicrob Chemother 42: 729–734PubMedCrossRefGoogle Scholar
  159. 159.
    Limia A, Jimenez ML, Delgado T, Sanchez I, Lopez S, Lopez-Brea M (1998) Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens. Rev Esp Quimioter 11: 216–220PubMedGoogle Scholar
  160. 160.
    Setchanova L, Tomasz A (1999) Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates from Bulgaria. J Clin Microbiol 37: 638–648PubMedGoogle Scholar
  161. 161.
    Kataja J, Huovinen P, Skurnik M, Seppala H (1999) Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance. Antimicrob Agents Chemother 43: 48–52PubMedGoogle Scholar
  162. 162.
    Orden B, Perez-Trallero E, Montes M, Martinez R (1998) Erythromycin resistance of Streptococcus pyogenes in Madrid. Pediatr Infect Dis J 17: 470–473PubMedCrossRefGoogle Scholar
  163. 163.
    Perez-Trallero E, Urbieta M, Montes M, Ayestaran I, Marimon JM (1998) Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur J Clin Microbiol Infec Dis 17: 25–31CrossRefGoogle Scholar
  164. 164.
    de Azavedo JC, Yeung RH, Bast DJ, Duncan CL, Borgia SB, Low DE (1999) Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada. Antimicrob Agents Chemother 43: 2144–2147PubMedGoogle Scholar
  165. 165.
    Kataja J, Seppala H, Skurnik M, Sarkkinen H, Huovinen P (1998) Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob Agents Chemother 42: 1493–1494PubMedGoogle Scholar
  166. 166.
    Luna VA, Cousin S, Jr., Whittington WL, Roberts MC (2000) Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates. Antimicrob Agents Chemother 44: 2503–2506CrossRefGoogle Scholar
  167. 167.
    Luna VA, Coates P, Eady EA, Cove JH, Nguyen TT, Roberts MC (1999) A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother 44: 19–25PubMedCrossRefGoogle Scholar
  168. 168.
    Santagati M, Iannelli F, Oggioni MR, Stefani S, Pozzi G (2000) Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrob Agents Chemother 44: 2585–2587CrossRefGoogle Scholar
  169. 169.
    Gay K, Stephens DS (2001) Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae J Infect Dis 184: 56–65CrossRefGoogle Scholar
  170. 170.
    Brennan L, Duignan J, Petitpas J, Anderson M, Fu W, Retsema J, Rainville J, Smyth D, Su W, Sutcliffe J (1998) CP-544372: MIC90 studies and killing kinetics against key respiratory tract pathogens, abst. F-124. In Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy p. 264, San Diego, California USAGoogle Scholar
  171. 171.
    Arpin C, Daube H, Tessier F, Quentin C (1999) Presence of mefA and mefE Genes in Streptococcus agalactiae. Antimicrob Agents Chemother 43: 944–946Google Scholar
  172. 172.
    Poutanen SM, de Azavedo J, Willey BM, Low DE, MacDonald KS (1999) Molecular characterization of multidrug resistance in Streptococcus mitis. Antimicrob Agents Chemother 43: 1505–1507Google Scholar
  173. 173.
    Fraimow H, Knob C (1997) Amplification of macrolide efflux pumps msr and mef from Enterococcus faecium by polymerase chain reaction. In 98th General Meeting of the American Society for Microbiology p. 22, American Society for Microbiology, Miami Beach, FloridaGoogle Scholar
  174. 174.
    Arpin C, Canron MH, Noury P, Quentin C (1999) Emergence of mefA and mefE genes in beta-haemolytic streptococci and pneumococci in France. J Antimicrob Chemother 44: 133–134PubMedCrossRefGoogle Scholar
  175. 175.
    Perreten V, Schwarz F, Boeglin M, Cresta L, Dawen G, Teuber M (1997) Antibiotic resistance spread in food. Nature 389: 801–802PubMedCrossRefGoogle Scholar
  176. 176.
    Sutcliffe J (1999) Resistance to macrolides mediated by efflux mechanisms. Curr Opin Investig Drugs 1: 403–412Google Scholar
  177. 177.
    Rosato A, H. V, Bonnefoy A, Chantot JF, Leclercq R (1998) A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. Antimicrob Agents Chemother 42: 1392–1396PubMedGoogle Scholar
  178. 178.
    Jones PM, George AM (1999) Subunit interactions in ABC transporter: towards a functional architecture. FEMS Microbiol Lett 179: 187–202PubMedCrossRefGoogle Scholar
  179. 179.
    Janosi L, Nakajima Y, Hashimoto H (1990) Characterization of plasmids that confer inducible resistance to 14-membered macrolides and streptogramin type B antibiotics in Staphylococcus aureus. Microbiol Immunol 34: 723–735Google Scholar
  180. 180.
    Eady EA, Ross JI, Tipper JL, Walters CE, Cove JH, Noble WC (1993) Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother 31: 211–217PubMedCrossRefGoogle Scholar
  181. 181.
    Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J (1999) Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother 43: 1062–1066PubMedGoogle Scholar
  182. 182.
    Martineau F, Picard FJ, Lansac N, Menard C, Roy PH, Ouellette M, Bergeron MG (2000) Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 44: 231–238CrossRefGoogle Scholar
  183. 183.
    Milton ED, Hewitt CL, Harwood CR (1992) Cloning and sequencing of a plasmid-mediated erythromycin determinant from Staphylococcus xylosus. FEMS Microbiol Lett 97: 141–147CrossRefGoogle Scholar
  184. 184.
    Singh KV, Malathum K, Murray BE (2001) Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Antimicrob Agents Chemother 45: 263–266PubMedCrossRefGoogle Scholar
  185. 185.
    Neu HC (1993) Activity of macrolides against common pathogens in vitro Arnette, Blackwell, Paris, FranceGoogle Scholar
  186. 186.
    Rodriguez AM, Olano C, Vilches C, Mendez C, Salas JA (1993) Streptomyces antibioticus contains at least three oleandomycin-resistance determinants, one of which shows similarity with proteins of the ABC-transporter superfamily. Mol Microbiol 8: 571–582PubMedCrossRefGoogle Scholar
  187. 187.
    Olano C, Rodriguez AM, Mendez C, Salas JA (1995) A second ABC transporter is involved in oleandomycin resistance and its secretion by Streptomyces antibioticus. Mol Microbiol 16: 333–343CrossRefGoogle Scholar
  188. 188.
    Schoner B, Geistlich M, Rosteck JP, Rao RN, Seno E, Reynolds P, Cox K, Burgett S, Hershberger C (1992) Sequence similarity between macrolide-resistance determinants and ATP-binding transport proteins. Gene 115: 93–96PubMedCrossRefGoogle Scholar
  189. 189.
    O’Neill MP, Eady EA, Radford A, Baumberg 5, Cove JH (1995) The use of PCR to isolate a putative ABC transporter from Saccharopolyspora erythraea. FEMS Microbiol Lett 131: 189–195CrossRefGoogle Scholar
  190. 190.
    Charvalos E, Tselentis Y, Hamzehpour Mm, Kiöhler T, Pechere J-C (1995) Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni. Antimicrob Agents Chemother 39: 2019–2022CrossRefGoogle Scholar
  191. 191.
    George AM (1996) Multidrug resistance in enteric and other gram-negative bacteria. FEMS Microb Lett 139: 1–10CrossRefGoogle Scholar
  192. 192.
    Clancy J, Dib-Hajj F, Petitpas JW, Yuan W (1997) Cloning and characterization of a novel macrolide efflux gene mreA from Streptococcus agalactiae. Antimicrob Agents Chemother 41: 2719–2723Google Scholar
  193. 193.
    Gervais C, Leclercq R (1999) The macrolide resistance gene mreA is ubiquitous in this bacterial species, abst. 840. In Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, p. 115, San Franscisco, CaliforniaGoogle Scholar
  194. 194.
    Parish T, Liu J, Nikaido H, Stoker NG (1997) A Mycobacterium smegmatis mutant with a defective inositol monophosphate phosphatase gene homolog has altered cell envelope permeability. J Bacteriol 179: 7827–7833PubMedGoogle Scholar
  195. 195.
    Martin PK, Li T, Sun D, Biek DP, Schmid MB (1999) Role in cell permeability of an essential two-component system in Staphylococcus aureus. J Bacteriol 181: 3666–3673Google Scholar
  196. 196.
    Hulten K, Gibreel A, Skold 0, Engstrand L (1997) Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 41: 2550–2553PubMedGoogle Scholar
  197. 197.
    Ross JI, Eady EA, Cove JH, Jones CE, Ratyal AH, Miller YW, Vyakrnam S, Cunliffe WJ (1997) Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother 41: 1162–1165PubMedGoogle Scholar
  198. 198.
    Karlsson M, Fellstrom C, Heldtander MU, Johansson KE, Franklin A (1999) Genetic basis of macrolide and lincosamide resistance in Brachyspira (Serpulina) hyodysenteriae. FEMS Microbiol Lett 172: 255–260CrossRefGoogle Scholar
  199. 199.
    Vester B, Garrett RA (1987) A plasmid-coded and site-directed mutation in Escherichia coli 23S RNA that confers resistance to erythromycin: implications for the mechanism of action of erythromycin. Biochimie 69: 891–900PubMedCrossRefGoogle Scholar
  200. 200.
    Wang G, Taylor DE (1998) Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother 42: 1952–1958PubMedGoogle Scholar
  201. 201.
    Wang G, Jiang Q, Taylor DE (1998) Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates. J Clin Microbiol 36: 2730–2731PubMedGoogle Scholar
  202. 202.
    Stone GG, Shortridge D, Versalovic J, Beyer J, Flamm RK, Graham DY, Ghoneim AT, Tanaka SK (1997) A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother 41: 712–714Google Scholar
  203. 203.
    Occhialini A, Urdaci M, Doucet-Populaire F, Bebear CM, Lamouliatte H, Megraud F (1997) Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother 41: 2724–2728PubMedGoogle Scholar
  204. 204.
    van Doom LJ, Debets-Ossenkopp YJ, Marais A, Sanna R, Megraud F, Kusters JG, Quint WG (1999) Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother 43: 1779–1782Google Scholar
  205. 205.
    Debets-Ossenkopp YJ, Brinkman AB, Kuipers EJ, Vandenbroucke-Grauls CM, Kusters JG (1998) Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 42: 2749–2751PubMedGoogle Scholar
  206. 206.
    Debets-Ossenkopp YJ, Sparrius M, Kusters JG, Kolkman JJ, Vandenbroucke-Grauls CM (1996) Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 142: 37–42CrossRefGoogle Scholar
  207. 207.
    Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K (1997) Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 41: 2621–2628PubMedGoogle Scholar
  208. 208.
    Versalovic J, Osato MS, Spakovsky K, Dore MP, Reddy R, Stone GG, Shortridge D, Flamm RK, Tanaka SK, Graham DY (1997) Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother 40: 283–286PubMedCrossRefGoogle Scholar
  209. 209.
    Wallace RJ, Jr., Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, Bottger EC (1996) Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 40: 1676–1681Google Scholar
  210. 210.
    Nash KA, Inderlied CB (1995) Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother 39: 2625–2630PubMedCrossRefGoogle Scholar
  211. 211.
    Meier A, Kirschner P, Springer B, Steingrube VA, Brown BA, Wallace RJ, Jr., Bottger EC (1994) Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother 38: 381–384CrossRefGoogle Scholar
  212. 212.
    Burman WJ, Stone BL, Brown BA, Wallace J, R.J., Bottger EC (1998) AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin. Diagn Microbiol Infect Dis 31: 369–371Google Scholar
  213. 213.
    Lucier TS, Heitzman K, Liu SK, Hu PC (1995) Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother 39: 2770–2773CrossRefGoogle Scholar
  214. 214.
    Stamm LV, Bergen HL (2000) A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate. Antimicrob Agents Chemother 44: 806–807PubMedCrossRefGoogle Scholar
  215. 215.
    van Doom LJ, Debets-Ossenkopp YJ, Marais A, Megraud F, Kusters JG, Quint WGV (1999) Rapid detection of mutations in the 23S rRNA gene associated with macrolide resistance in Helicobacter pylori by PCA and reverse hybridization. In 39th Annual International Conference on Antimicrobial Agents and Chemotherapy p. 263, American Society for Microbiology, Washington, DC, San Francisco, CaliforniaGoogle Scholar
  216. 216.
    Vannuffel P, Di Giambattista M, Morgan EA, Cocito C (1992) Identification of a single base change in ribosomal RNA leading to erythromycin resistance. J Biol Chem 267: 8377–8382PubMedGoogle Scholar
  217. 217.
    Roberts AN, Hudson GS, Brenner S (1985) An erythromycin-resistance gene from an erythromycin-producing strain of Arthrobacter sp. Gene 35: 259–270PubMedCrossRefGoogle Scholar
  218. 218.
    Uchiyama H, Weisblum B (1985) N-Methyl transferase of Streptomyces erythraeus that confers resistance to the macrolide-lincosamide-streptogramin B antibiotics: amino acid sequence and its homology to cognate R-factor enzymes from pathogenic bacilli and cocci. Gene 38: 103–110PubMedCrossRefGoogle Scholar
  219. 219.
    Bibb MJ, Janssen GR, Ward JM (1985) Cloning and analysis of the promoter region of the erythromycin resistance gene (ermE) of Streptomyces erythraeus. Gene 38: 215–226Google Scholar
  220. 220.
    Epp JK, Burgett SG, Schoner BE (1987) Cloning and nucleotide sequence of a carbomycinresistance gene from Streptomyces thermotolerans. Gene 53: 73–83Google Scholar
  221. 221.
    Pernodet JL, Blondelet-Rouault MH, Guerineau M (1993) Resistance to spiramycin in Streptomyces ambofaciens the producer organism, involves at least two different mechanisms. J Gen Microbiol 139: 1003–1011PubMedCrossRefGoogle Scholar
  222. 222.
    Gandecha AR, Cundliffe E (1996) Molecular analysis of tlrD an MLS resistance determinant from the tylosin producer, Streptomyces fradiae. Gene 180: 173–176Google Scholar
  223. 223.
    Peschke U, Schmidt H, Zhang HZ, Piepersberg W (1995) Molecular characterization of the lincomycin-production gene cluster of Streptomyces lincolnensis 78–11. Mol Microbiol 16: 1137–1156PubMedCrossRefGoogle Scholar
  224. 224.
    Inouye M, Morohoshi T, Horinouchi S, Beppu T (1994) Cloning and sequences of two macrolideresistance-encoding genes from mycinamicin-producing Micromonospora griseorubida. Gene 141: 39–46Google Scholar
  225. 225.
    Xue Y, Zhao L, Liu HW, Sherman DH (1998) A gene cluster for macrolide antibiotic biosynthesis in Streptomyces venezuelae: architecture of metabolic diversity. Proc Natl Acad Sci USA 95: 12111–12116PubMedCrossRefGoogle Scholar
  226. 226.
    Fujisawa Y, Weisblum B (1981) A family of r-determinants in Streptomyces spp. that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics. J Bacteriol 146: 621–631PubMedGoogle Scholar
  227. 227.
    Calcutt MJ, Cundliffe E (1990) Cloning of a lincosamide resistance determinant frm Streptomyces caelestis the producer of celesticetin, and characterization of the resistance mechanism. J Bacteriol 172: 4710–4714PubMedGoogle Scholar
  228. 228.
    Jenkins G, Zalacain M, Cundliffe E (1989) Inducible ribosomal RNA methylation in Streptomyces lividans conferring resistance to lincomycin. J Gen Microbiol 135: 3281–3288PubMedGoogle Scholar
  229. 229.
    Murphy E, Huwyler L, de Freire Bastos MdC (1985) Transposon Tn554: complete nucleotide sequence and isolation of transposition-defective and antibiotic-sensitive mutants. EMBO J 4: 3357–3365PubMedGoogle Scholar
  230. 230.
    Shaw JH, Clewell DB (1985) Complete nucleotide sequence of macrolide-lincosamide-strepto-gramin B-resistance transposon Tn91 7 in Streptococcus faecalis. J Bacteriol 164: 782–796Google Scholar
  231. 231.
    Horinouchi S, Weisblum B (1982) Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics. J Bacteriol 150: 804–814PubMedGoogle Scholar
  232. 232.
    Rasmussen JL, Odelson DA, Macrina FL (1986) Complete nucleotide sequence and transcription of ermF a macrolide-lincosamide-streptogramin B resistance determinant from Bacteroides fragilis. J Bacteriol 168: 523–533Google Scholar
  233. 233.
    Berryman DI, Lyristis M, Rood JI (1994) Cloning and sequence analysis of ermQ the predominant macrolide-lincosamide-streptogramin B resistance gene in Clostridium perfringens. Antimicrob Agents Chemother 38: 1041–1046CrossRefGoogle Scholar
  234. 234.
    Serwold-Davis TM, Groman NB (1988) Identification of a methylase gene for erythromycin resistance within the sequence of a spontaneously deleting fragment of Corynebacterium diphtheriae plasmid pNG2. FEMS Microbiol Lett 46: 7–14CrossRefGoogle Scholar
  235. 235.
    McGee L, Klugmann KP, Wasas A, Capper T, Brink A (2001) Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and enn(A)) in South Africa. Antimicrob Agents Chemother 45: 1595–1598PubMedCrossRefGoogle Scholar
  236. 236.
    Perreten V, Schwarz FV, Teuber M, Levy SB (2001) Mdt(A), a new efflux protein conferring multiple antibiotic resistance in Lactococcus lactis and Escherichia coli. Antimicrob Agents Chemother 45: 1109–1114CrossRefGoogle Scholar

Copyright information

© Springer Basel AG 2002

Authors and Affiliations

  • Joyce A Sutcliffe
    • 1
  • Roland Leclercq
    • 2
  1. 1.Rib-X Pharmaceuticals25 Science ParkNew HavenUSA
  2. 2.Department of MicrobiologyCHU, Côte de Nacre, Av. Côte de NacreCaenFrance

Personalised recommendations